Drug and medical device maker Abbott Laboratories has reported net sales of $9.62bn for the second quarter ended 30 June 2011, an increase of 9%, compared to $8.82bn for the same period in 2010.
Subscribe to our email newsletter
Abbott‘s net earnings were $1.94bn, compared to $1.29bn for the same period in the prior year.
The company’s operating earnings was $1.77bn for the second quarter ended 30 June 2011, as compared to $1.61bn for the same period in 2010.
For the six months ended 30 June 2011 net sales were $18.66bn, compared to $16.52bn for the same period in 2010.
Net earnings increased from $2.3bn in the last year to $2.81bn, for the six months ended 30 June 2011.
For the six months ended 30 June 2011, the company’s operating earnings were $3.07bn , as compared to $3.08bn for the same period in 2010.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.